Abstract
Abstract
Purpose
Cardiovascular diseases, the world’s leading cause of death, are linked to changes in tissue mechanical and material properties that affect the signaling of cells in the damaged tissue. It is hard to predict the effect of altered physical cues on cell signaling though, due to the large number of molecules potentially involved. Our goal is to identify genes and molecular networks that mediate cellular response to cardiovascular disease and cardiovascular-related forces.
Methods
We used custom computer code, statistics, and bioinformatics tools to meta-analyze PubMed-indexed citations for mentions of genes and proteins.
Results
We identified the names and frequencies of genes studied in the context of mechanical cues (shear, strain, stiffness, and pressure) and major diseases (stroke, myocardial infarction, peripheral arterial disease, deep vein thrombosis). Using statistical and bioinformatics analyses of these biomolecules, we identified the cellular functions and molecular gene sets linked to cardiovascular diseases, biophysical cues, and the overlap between these topics. These gene sets formed independent molecular circuits that each related to different biological processes, including inflammation and extracellular matrix remodeling.
Conclusion
Computational analysis of cardiovascular and mechanobiology publication data can be used for discovery of evidence-based, data-rich gene networks suitable for future systems biology modeling of mechanosignaling.
Funder
deutsche forschungsgemeinschaft (dfg) cluster of excellence ”physics of life of tu dresden”
university of california, santa barbara
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biomedical Engineering,Biomaterials,Medicine (miscellaneous)
Reference58 articles.
1. Centers for Disease Control. Global health protection and security: Cardiovascular diseases. https://www.cdc.gov/globalhealth/healthprotection/ncd/cardiovascular-diseases.html (2021). Accessed: 2021-06-20.
2. Virani SS, Alonso A, Aparicio HJ, et al. American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee. Circulation. 2021;143(8):e254. https://doi.org/10.1161/CIR.0000000000000950.
3. Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990--2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982.
4. Graham G. Disparities in cardiovascular disease risk in the United States. Curr Cardiol Rev. 2015;11(3):238.
5. Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021;397(10292):2385.